Peripheral neuropathy Board decisions

The Board remands the claims for service connection for a skin condition and right hand condition due to insufficient evidence.

The Board remands the claims for service connection for various knee and foot conditions, including painful scars from surgery, as a medical opinion regarding their etiology is needed.

The Board remands the claims for service connection for heart condition, diabetes mellitus, and peripheral neuropathy, as well as the claim for special monthly compensation (SMC) based on aid and attendance/housebound status, due to a pre-decisional duty to assist error.

The Veteran's request for an extension of time to file an appeal from the September 2019 rating decision that granted service connection for left and right lower extremity peripheral neuropathy was denied, and the attempted appeal is therefore dismissed.

The Board granted service connection and ratings for the veteran's diabetes mellitus type II, arteriosclerotic heart disease, hypertension, and diabetic peripheral neuropathy of both lower extremities.

The Board denied benefits for a child born with birth defects and spina bifida under 38 U.S.C. § 1805, as the appellant's mother is not a Vietnam veteran and there is no evidence of a diagnosis of spina bifida.

The Board remands the claim for service connection for peripheral neuropathy to obtain a new VA medical opinion due to inadequate previous opinions.

The Board granted an initial disability rating of 30 percent for peripheral neuropathy impacting the right femoral and internal saphenous nerves, but remanded the issue of entitlement to a total disability rating based upon individual unemployability due to service-connected disabilities (TDIU).

The Board granted a 40 percent rating for peripheral neuropathy of the right and left lower extremities prior to April 21, 2021, but denied ratings in excess of 50 percent for PTSD and 40 percent for peripheral neuropathy since that date.

The Board remands the service connection claims for bilateral hearing loss, tinnitus, back condition, peripheral neuropathy (hands), traumatic brain injury (TBI), and respiratory issues, as well as the nonservice-connected pension benefits claim, due to an inadequate statement of reasons and bases in its January 2024 decision.

The Board remands the claims for additional medical inquiry regarding whether medication used for service-connected heart disease aggravates upper and lower extremity peripheral neuropathy/radiculopathy.

The Board denied service connection for peripheral neuropathy in the right and left lower extremities, finding no evidence of a nexus between the conditions and the Veteran's military service.

The Board remands the claims for service connection for a back condition and bilateral foot peripheral neuropathy to obtain missing VA treatment records, schedule a new examination, and provide opinions on the etiology of these conditions.

The Board remands the veteran's claims for service connection for various disabilities, including chloracne, diabetes, peripheral neuropathy, major depressive disorder, hypertension, erectile dysfunction, and a kidney disability, to obtain further development in accordance with the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022 (PACT Act).

The Board remands the issues of entitlement to service connection for left and right foot sensorimotor peripheral neuropathy, as well as diabetes, due to a need for additional development.

The Board remands the claims for service connection for various conditions, including a chronic liver disorder and diabetes mellitus, type II (DMII), due to insufficient medical evidence and required toxic exposure risk activity (TERA) opinions.

The Board granted service connection for bilateral lower extremity peripheral neuropathy based on the evidence showing a nexus between the Veteran's current nerve disability and his exposure to Agent Orange during active service in Vietnam.

The Board granted service connection for rheumatoid arthritis and peripheral neuropathy of the upper and lower extremities, as well as special monthly compensation based on a need for regular aid and attendance.

The Board remands the issue for a new VA examination to reconcile findings and address whether an extraschedular rating is warranted.

The Board remands the claims for increased ratings for diabetic peripheral neuropathy of the bilateral lower extremities due to non-compliance with previous remand directives.